Search

Displaying results 191 - 200 of 2955 in total
  1. Drug

    Shea butter

    go.drugbank.com/drugs/DB14311
    Approved

    Shea butter is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Products: EM Shea Butter Cream
  2. Drug

    Fenofibrate

    go.drugbank.com/drugs/DB01039
    ApprovedInvestigational

    [L8588,L8591] Fenofibrate was granted FDA approval on 31 December 1993.[L8585]

    Products: Lipidil Ez, FENOFIBRATO EG
  3. Drug

    Tazobactam

    go.drugbank.com/drugs/DB01606
    ApprovedInvestigational

    Piperacillin-tazobactam was initially approved by the FDA in 1994, and ceftolozane-tazobactam was approved by the FDA in 2014[FDA label], providing wider antibacterial coverage for gram-negative infections … In June 2019, ceftolozane-tazobactam was approved by the FDA for treating hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia, which are significant causes of morbidity

    Mixtures: TAZOCIN EF INJECTION 4.5G, PIPERACILLINA E TAZOBACTAM KABIProducts: TAZOCIN EF
  4. Drug

    Acetylsalicylic acid

    go.drugbank.com/drugs/DB00945
    ApprovedInvestigationalVet approved

    It should be kept out of reach from young children, toddlers, and infants [FDA label]. … This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) [FDA label].

    Mixtures: Anacin ES, TOMAPIRINA ESInternational brands: Nu-seals
  5. Drug

    Potassium bicarbonate

    go.drugbank.com/drugs/DB11098
    ApprovedInvestigational

    [T141] It is registered in the FDA under the section of suitable, safe and effective ingredients for OTC antacids.[L1836] This FDA denomination classifies potassium bicarbonate as a GRAS ingredient.

    Products: Klor-con/ef, KLOR-Con/EF
  6. Drug

    Bezafibrate

    go.drugbank.com/drugs/DB01393
    ApprovedInvestigational

    Antilipemic agent that lowers cholesterol and triglycerides. It decreases low density lipoproteins and increases high density lipoproteins.

    Products: BEZAFIBRAT RATIO 200MG FTA
  7. Drug

    Ceftazidime

    go.drugbank.com/drugs/DB00438
    ApprovedInvestigational

    [L32935] Ceftazidime was approved by the FDA on July 19, 1985, and is currently available either alone or in combination with the non-β-lactam β-lactamase inhibitor [avibactam] to treat a variety of

    Products: CEFTAZIDIMA EG, Fortum 2 g Pulver zur Herstellung einer Injektions- oder Infusionslösung
  8. Drug

    Galantamine

    go.drugbank.com/drugs/DB00674
    ApprovedInvestigational

    [A182993] The drug was approved by the FDA in 2001 for the treatment of mild to moderate dementia of the Alzheimer's type.

    Products: Reminyl ER, REMINYL ER
  9. Drug

    Riluzole

    go.drugbank.com/drugs/DB00740
    ApprovedInvestigational

    A glutamate antagonist (receptors, glutamate) used as an anticonvulsant (anticonvulsants) and to prolong the survival of patients with amyotrophic lateral sclerosis. Riluzole is marketed as Rilutek by Sanofi.

    Products: RILUZOL AL 50MG FTA
  10. Drug

    Levofloxacin

    go.drugbank.com/drugs/DB01137
    ApprovedInvestigational

    [A31453,A190756] Levofloxacin was first approved by the FDA in 1996, and was approved in Canada and several South American countries soon after.[A190663]

    Products: LEVOFLOXACINA EG, LEVOFLOX - CT 500MG FTA